Skip to main content

Szukaj

Reset all filters
47 Result(s)
Sortuj według

Open Innovation at Boehringer Ingelheim

Open Innovation at Boehringer Ingelheim

Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines
Our Partners Harvard

Our Partners Harvard

Brock Reeve, Executive Director of the Harvard Stem Cell Institute, talks about the importance of working together to tackle the challenge of fibrosis.
Kodeks postępowania dostawców

Kodeks postępowania dostawców

BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements.
Equestrian sports technology

Equestrian sports technology

Learn about new trends in equine health and get insights into the human-horse relationship!
More Potential Overview

More Potential Overview

Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
BI Access to Healthcare Strategy_Availability

BI Access to Healthcare Strategy_Availability

Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering More Health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.
Championing novel science

Championing novel science

Dr. Vikas Mohan Sharma announces FDA fast-track designation for BI 1358894 as potential treatment for Borderline Personality Disorder.
Advancing regenerative medicine

Advancing regenerative medicine

Strategic partnerships play a key role in helping the company accelerate the next generation of breakthroughs.
Światowy Dzień Chorób Rzadkich 2021

Światowy Dzień Chorób Rzadkich 2021

Rzadkie, ale nie zapomniane: dlaczego wsparcie medyczne dla około 30 milionów osób w UE cierpiących na choroby rzadkie1 jest nie do przecenienia
More Health Overview

More Health Overview

Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Stem cells a new frontier

Stem cells a new frontier

Stem cells may be a game changer for the development of new veterinary treatments. Read this story to find out why.
Być niezależnym

Być niezależnym

Kultura korporacyjna Boehringer Ingelheim opiera się na wartościach, które są stosowane od momentu założenia firmy w 1885 roku.
Women in STEM 2022

Women in STEM 2022

Meet three of Boehringer Ingelheim's female scientists and learn why and how women are making a difference in STEM.